Tuberculosis

ClinicalAugust 7, 2026

Clinical Trial on Community-based TB Preventive Therapy Delivery Initiated

A clinical trial is evaluating the effectiveness of community-based delivery of TB preventive therapy (TPT) compared to standard care.

ClinicalJuly 31, 2026

Study on Rifapentine and Isoniazid for TB Prevention in Children Under 13

A clinical trial is underway to evaluate the safety and efficacy of daily Rifapentine combined with Isoniazid for tuberculosis prevention in children under 13, including those with HIV.

ClinicalJuly 19, 2026

Otsuka's OPC-167832 Trial for Drug-Susceptible TB Shows Promise Against Standard Regimen

A trial is underway to evaluate the safety and efficacy of OPC-167832 in combination with delamanid and bedaquiline for drug-susceptible TB.

ClinicalJuly 17, 2026

BCG Vaccine: Intravenous Administration Shows Superior Efficacy Over Traditional Routes

Recent studies suggest that intravenous administration of BCG vaccine offers better protection against tuberculosis than traditional cutaneous methods.

RegulatoryJuly 15, 2026

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Roche's Elecsys IGRA TB test has received CE Mark approval, enabling rapid and efficient tuberculosis infection testing.

ClinicalJuly 13, 2026

Kaiser Permanente Trials Educational Video to Improve LTBI Treatment Completion

A randomized trial will assess the impact of a 3-minute educational video on LTBI treatment completion rates.

ClinicalJuly 12, 2026

NIAID Launches Study on Natural History of Tuberculosis with Active Recruitment

The National Institute of Allergy and Infectious Diseases is recruiting individuals with active or latent tuberculosis for a study on the disease's natural history.

RegulatoryJuly 9, 2026

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Roche's Elecsys IGRA TB test has received CE Mark approval, enabling rapid and automated tuberculosis infection testing.

ClinicalJuly 6, 2026

Evaluation of LTBI Screening Methods in HIV Patients in Liberia

A study is underway to compare IGRA and TST for latent TB screening in HIV-positive individuals in Liberia.

ClinicalJuly 3, 2026

Study Evaluates eDOT vs Traditional DOT for TB Treatment Adherence

A randomized controlled trial is assessing the non-inferiority of electronic DOT compared to traditional DOT for TB treatment adherence.

StrategyJune 24, 2026

FDA Approves First Generic of Priftin (rifapentine) Tablets

The FDA has approved the first generic version of Priftin (rifapentine) tablets for treating active pulmonary tuberculosis.

Companies

Assets

Recent signals(11)

Clinical Trial on Community-based TB Preventive Therapy Delivery Initiated

Study on Rifapentine and Isoniazid for TB Prevention in Children Under 13

Otsuka's OPC-167832 Trial for Drug-Susceptible TB Shows Promise Against Standard Regimen

BCG Vaccine: Intravenous Administration Shows Superior Efficacy Over Traditional Routes

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Kaiser Permanente Trials Educational Video to Improve LTBI Treatment Completion

NIAID Launches Study on Natural History of Tuberculosis with Active Recruitment

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Evaluation of LTBI Screening Methods in HIV Patients in Liberia

Study Evaluates eDOT vs Traditional DOT for TB Treatment Adherence

FDA Approves First Generic of Priftin (rifapentine) Tablets

Upcoming catalysts

Indications

Get signals before the market moves